Fig. 1: SORBS2 downregulation in ccRCC tissues and its association with poor prognosis. | Cell Death & Disease

Fig. 1: SORBS2 downregulation in ccRCC tissues and its association with poor prognosis.

From: RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability

Fig. 1: SORBS2 downregulation in ccRCC tissues and its association with poor prognosis.The alternative text for this image may have been generated using AI.

A Expression analysis by qRT-PCR of SORBS2 mRNA in different tissues. B Expression analysis by western blot of SORBS2 protein in different tissues. C Immunohistochemistry analysis of SORBS2 in different tissues, scale bar = 100 μm. D Relative FPKM (fragments per kilobase per million) of SORBS2 in different tumor grades. E Kaplan–Meier survival curves comparing overall survival in ccRCC patients with high or low SORBS2 expression; the average expression of SORBS was used as a cut-off value for grouping. ***P < 0.001.

Back to article page